SEC Info - Hoffman Michael B - ‘4’ for 1/31/20 re: Annovis Bio, Inc.

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Hoffman Michael B

(Last)

(First)

(Middle)

C/O ANNOVIS BIO, INC.

1055 WESTLAKES DRIVE, SUITE 300

(Street)

BERWYN

19312

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Annovis Bio, Inc. [ ANVS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
1/31/20

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	1/31/20		P		33,333 ⁽¹⁾	A	$6	47,619	D
Common Stock	1/31/20		C		158,730	A	⁽²⁾	206,349	D
Common Stock	1/31/20		C		1,137,942	A	⁽³⁾	1,344,291	D
Common Stock	1/31/20		C		55,884	A	$4.8 ⁽⁴⁾	1,400,175	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Series A-1 Preferred Stock	⁽²⁾	1/31/20		C			222,222	⁽²⁾	⁽²⁾	Common Stock	158,730	$0	0	D
Series A Preferred Stock	⁽³⁾	1/31/20		C			1,593,118	⁽³⁾	⁽³⁾	Common Stock	1,137,942	$0	0	D
Convertible Note	⁽⁴⁾	1/31/20		C			55,884 ⁽⁴⁾	⁽⁴⁾	⁽⁴⁾	Common Stock	55,884	$4.8	0	D

Explanation of Responses:

(1) The reporting person acquired these shares in the initial public offering ("IPO") of Annovis Bio, Inc. ("Annovis").

(2) Each share of Series A-1 Preferred Stock automatically converted into common stock of Annovis upon the closing of the IPO at a conversion ratio of one for 0.7143.

(3) Each share of Series A Preferred Stock automatically converted into common stock of Annovis upon the closing of the IPO at a conversion ratio of one for 0.7143.

(4) The convertible notes have a maturity date of December 31, 2023. The Convertible Notes automatically converted into common stock of Annovis upon the closing of the IPO at a conversion rate equal to the principal amount of the note, plus accrued and unpaid interest, divided by $4.80 (80% of the IPO price).

	/s/ Michael Hoffman	2/4/20
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

____________ Transaction Codes:
C	Conversion of derivative security.
P	Open market or private purchase of non-derivative or derivative security.

Hoffman Michael B – ‘4’ for 1/31/20 re: Annovis Bio, Inc.

On: Wednesday, 2/5/20, at 6:05am ET · For: 1/31/20 · Accession #: 1104659-20-10943 · File #: 1-39202

Previous ‘4’: ‘4’ on 7/29/19 for 7/26/19 · Next: ‘4/A’ on 7/6/20 for 7/1/20 · Latest: ‘4/A’ on 11/22/23 for 11/20/23

Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 — SEA’34
Filing Table of Contents

This ‘4’ Document is an XML Data File that may be rendered in various formats:

Hoffman Michael B – ‘4’ for 1/31/20 re: Annovis Bio, Inc.

On: Wednesday, 2/5/20, at 6:05am ET · For: 1/31/20 · Accession #: 1104659-20-10943 · File #: 1-39202

Previous ‘4’: ‘4’ on 7/29/19 for 7/26/19 · Next: ‘4/A’ on 7/6/20 for 7/1/20 · Latest: ‘4/A’ on 11/22/23 for 11/20/23

Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 — SEA’34Filing Table of Contents

This ‘4’ Document is an XML Data File that may be rendered in various formats:

Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 — SEA’34
Filing Table of Contents